UAT Group Subsidiary, The Dreaming Company Announces Hygieia Eye Gel
August 02, 2022 08:30 ET
|
Umbra Applied Technologies Group, Inc.
Tampa, FL, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Umbra Applied Technologies Group, Inc. (OTC Pink UATG) ("UAT Group") announced today that its subsidiary, The Dreaming Company, is expanding on its...
UAT Group Subsidiary, The Dreaming Company Announces Hygieia Bedding Line
July 26, 2022 08:00 ET
|
Umbra Applied Technologies Group, Inc.
Tampa, FL, July 26, 2022 (GLOBE NEWSWIRE) -- Umbra Applied Technologies Group, Inc’s (OTC Pink: UATG) ("UAT Group"), announced today that its subsidiary, The Dreaming Company, is expanding on the...
Institute of Biomedical Research Corp Announces Purchase of Biomedical and Nutraceutical Assets
July 22, 2022 06:00 ET
|
Institute of Biomedical Research Corp.
SEATTLE, WA, July 22, 2022 (GLOBE NEWSWIRE) -- Institute of Biomedical Research Corp. (OTC Pink: MRES), a diversified biomedical company, announces the purchase of biomedical and nutraceutical...
By 2028, Demand for Electrophysiology Market Size $14.84 Billion at 10.2% CAGR Lead by Atrial Fibrillation (11% CAGR in 2028) Global Analysis by The Insight Partners
June 20, 2022 07:01 ET
|
The Insight Partners
New York, June 20, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Electrophysiology Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product...
NeuroSigma Announces That a Team Led by UCLA Researchers Receives NIH Grant to Conduct a Multicenter Trial of eTNS for Pediatric ADHD
June 14, 2022 11:00 ET
|
NeuroSigma, Inc.
Double-blind randomized controlled trial will enroll up to 225 children at UCLA and Seattle Children’s Hospital NeuroSigma will provide Monarch eTNS Systems and funding for long-term follow-up ...
SPO Global Inc. Discusses Company’s Medical Devices
June 08, 2022 09:00 ET
|
SPO Global Inc.
Shandong, China, June 08, 2022 (GLOBE NEWSWIRE) -- SPO Global Inc. (OTC PINK: SPOM), a healthcare and biotech company, today provides an in depth discussion of the company’s medical devices. ...
SPO Global Inc. Issues Letter to Shareholders
May 10, 2022 09:27 ET
|
SPO Global Inc.
Shandong, China, May 10, 2022 (GLOBE NEWSWIRE) -- SPO Global Inc. (OTC PINK: SPOM), a healthcare and biotech company, today provides a corporate update and letter from CEO Fengyou Lu. Dear...
Edmund Optics® Expands in Response to Rapid Growth
April 28, 2022 09:00 ET
|
Edmund Optics (edmundoptics.com)
BARRINGTON, N.J., April 28, 2022 (GLOBE NEWSWIRE) -- Edmund Optics®, a leading global manufacturer and supplier of optical components, has announced the opening of a new facility in Cherry Hill, NJ,...
NeuroSigma Announces King’s College London Team Receives MHRA Approval to Commence Largest Clinical Trial of eTNS for Pediatric ADHD to Date
April 07, 2022 11:00 ET
|
NeuroSigma, Inc.
Double-blind randomized controlled trial of eTNS for pediatric ADHD will enroll up to 150 participants at two sites in London and Southampton NeuroSigma’s Monarch eTNS System and electric patches to...
SPO Global Inc. Announces Partnership Between Cinuo Traditional Chinese Medicine, Science and Technology Group Co., Ltd and Spun SPO Medical (Group), a subsidiary of Gerbang Medical
March 29, 2022 09:00 ET
|
SPO Global Inc.
Shandong, China, March 29, 2022 (GLOBE NEWSWIRE) -- SPO Global Inc. (OTC PINK: SPOM), a healthcare and biotech company, today announced a partnership Between Cinuo Traditional Chinese Medicine,...